Jane Street
SRNE

Jane Street’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Jane Street’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-407,300
Closed -$361K – 10494
2022
Q4 		$361K Sell
407,300
-173,400
-30% -$230K ﹤0.01% 6694
2022
Q3 		$912K Buy
580,700
+121,800
+27% +$276K ﹤0.01% 5572
2022
Q2 		$922K Sell
458,900
-72,200
-14% -$125K ﹤0.01% 5635
2022
Q1 		$1.24M Sell
531,100
-649,200
-55% -$2.02M ﹤0.01% 5692
2021
Q4 		$5.49M Buy
1,180,300
+373,300
+46% +$2.32M ﹤0.01% 2710
2021
Q3 		$6.16M Sell
807,000
-183,200
-19% -$1.55M ﹤0.01% 2433
2021
Q2 		$9.6M Buy
990,200
+314,900
+47% +$2.51M ﹤0.01% 1768
2021
Q1 		$5.58M Sell
675,300
-674,300
-50% -$7.12M ﹤0.01% 2256
2020
Q4 		$9.21M Sell
1,349,600
-511,200
-27% -$4.11M ﹤0.01% 1480
2020
Q3 		$20.7M Buy
1,860,800
+817,200
+78% +$7.48M 0.01% 761
2020
Q2 		$6.55M Buy
+1,043,600
New +$4M ﹤0.01% 1550
2020
Q1 		– Sell
-23,800
Closed -$80K – 6197
2019
Q4 		$80K Buy
+23,800
New +$56.7K ﹤0.01% 4869
2018
Q3 		– Sell
-11,000
Closed -$79K – 5889
2018
Q2 		$79K Buy
+11,000
New +$74.8K ﹤0.01% 4771

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Jane Street's SRNE Position: Q1 2023 in Review

Jane Street sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 731,024 shares — an estimated $648K sold.

Jane Street first reported a position in SRNE in Q1 2014 and held it in 17 quarters. The position peaked at $9.32M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Jane Street reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 731,024 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $648K.
  • Jane Street first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 17 quarters.
  • Jane Street's Sorrento Therapeutics, Inc. position peaked at $9.32M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.